David J. Adelstein – författare
Visar alla böcker från författaren David J. Adelstein. Handla med fri frakt och snabb leverans.
2 produkter
2 produkter
Inbunden, Engelska, 2005
1 680 kr
Skickas inom 10-15 vardagar
This volume reviews recent progress made in the surgical, radiotherapeutic, and chemotherapeutic management of squamous cell head and neck cancer, with particular emphasis on the coordination of these treatment modalities. The surgical issues addressed include laser-based surgery, larynx preservation salvage surgery, and neck management after non-operative treatment. Current radiation therapies discussed include deffinitive radiation for larnx cancer, brachytherapy, altered fractionation radiation, intensity modulated radiation therapy and the importance of tumor hypoxia. Chapters also review the role of chemotherapy in sequential, concurrent, and adjuvant multi-modality treatment schedules. Squamous Cell Head and Neck Cancer presents the advances that have been made on multiple fronts in the treatment of this disease and will serve as both a review of recent success and a blueprint for future investigation.
E-bok
PDF, Engelska, 20072 036 kr
Läs direkt efter köp
Leading expert physicians and investigators from around the world review the state-of-the-art in the management of squamous cell head and neck cancer, with emphasis on coordinating different treatment modalities. The authors address several surgical issues, including laser-based surgery, larynx preservation approaches, salvage surgery, and neck management after non-operative treatment. They also discuss definitive radiation for larynx cancer, brachytherapy, altered fractionation radiation, intensity modulated radiation therapy, and the importance of tumor hypoxia, as well as the role of chemotherapy in sequential, concurrent, and adjuvant multi-modality treatment schedules. Other topics of special interest include targeted and gene therapies, multimodality management of nasopharyngeal cancer, chemoprevention, toxicity modification, quality of life outcomes, symptom palliation, and epidemiology.